Swissfinity is a pan-European investment group with a focus on biotechnology, in particular cell and gene therapy and accompanying technologies. It supports its portfolio companies and external partners not only with capital, but also with strategic advice and its extensive network.
finances
Thomas Middelhoff supports Swissfinity with his international management experience, his strong network and his expertise in growth and negotiation strategies, merger & acquisition, and transaction consulting in order to strengthen the investment group's position in the field of biotechnology in a targeted and sustainable way.
With far-sighted investments and strategic support from high-potential companies, innovations in medicine and biotechnology are to be driven forward in order to revolutionize healthcare, improve lives, and create sustainable value for investors. We are pleased to be able to advise Swissfinity on this journey!
.jpeg)
.jpg)
.jpg)
.jpg)
.jpg)
.png)
.png)
.jpg)
.jpg)